Matches in Wikidata for { <http://www.wikidata.org/entity/Q66403466> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q66403466 description "assaig clínic" @default.
- Q66403466 description "clinical trial" @default.
- Q66403466 description "clinical trial" @default.
- Q66403466 description "clinical trial" @default.
- Q66403466 description "clinical trial" @default.
- Q66403466 description "ensaio clínico" @default.
- Q66403466 description "ensayo clínico" @default.
- Q66403466 description "ensayu clínicu" @default.
- Q66403466 description "essai clinique" @default.
- Q66403466 description "klinisch onderzoek" @default.
- Q66403466 description "клінічне випробування" @default.
- Q66403466 name "Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)" @default.
- Q66403466 name "Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia" @default.
- Q66403466 type Item @default.
- Q66403466 label "Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)" @default.
- Q66403466 label "Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia" @default.
- Q66403466 prefLabel "Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)" @default.
- Q66403466 prefLabel "Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia" @default.
- Q66403466 P1050 Q66403466-4B935ACC-B2EA-40FF-81C5-87788CBB990C @default.
- Q66403466 P1132 Q66403466-E9CC5053-5A89-47CE-A294-F9923B7D2923 @default.
- Q66403466 P1476 Q66403466-AB5E682F-D8AB-4FBD-8087-09AF9B15C935 @default.
- Q66403466 P17 Q66403466-514E0213-5620-48AD-9B9A-09677DD0569C @default.
- Q66403466 P2899 Q66403466-713C7266-612A-4378-9913-73053D6564C7 @default.
- Q66403466 P3098 Q66403466-F56196BB-AAF6-4254-9EA5-158E40A76D15 @default.
- Q66403466 P31 Q66403466-0C4DCA0D-02AC-46A4-A027-18DF9D3CBD80 @default.
- Q66403466 P4844 Q66403466-12E7E4FA-BAA5-4A23-8CF3-000EE17AB1C3 @default.
- Q66403466 P580 Q66403466-38206578-1036-49FB-B86A-573D704BCC84 @default.
- Q66403466 P582 Q66403466-04F5E1C4-4475-4874-8095-18B63BC16559 @default.
- Q66403466 P6099 Q66403466-969013F1-CBA4-48AD-B35B-4677A6A57907 @default.
- Q66403466 P6099 Q66403466-F6170BAD-60B6-4EDF-BC3A-11FAA6F4759D @default.
- Q66403466 P8363 Q66403466-82DCC356-7E2C-480E-A2F5-F767E8EE6988 @default.
- Q66403466 P859 Q66403466-6FF0ACA5-29D8-4BFF-A642-2C750E46BFF4 @default.
- Q66403466 P1050 Q29496 @default.
- Q66403466 P1132 "+68" @default.
- Q66403466 P1476 "A Phase Ib/II Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)" @default.
- Q66403466 P17 Q30 @default.
- Q66403466 P2899 "+18" @default.
- Q66403466 P3098 "NCT02773732" @default.
- Q66403466 P31 Q30612 @default.
- Q66403466 P4844 Q27260984 @default.
- Q66403466 P580 "2016-12-16T00:00:00Z" @default.
- Q66403466 P582 "2020-06-01T00:00:00Z" @default.
- Q66403466 P6099 Q42824440 @default.
- Q66403466 P6099 Q5452194 @default.
- Q66403466 P8363 Q78089383 @default.
- Q66403466 P859 Q501758 @default.